Type 2 Diabetes · Currently recruiting
Study of oral zenagamtide tablets compared with placebo in adults with type 2 diabetes treated with metformin, an SGLT2 inhibitor, or both.
Condition: Type 2 Diabetes
Status: Recruiting
Protocol: NN9487-8450
Site: EndoTrials Clinical Research Center, La Mesa, California
Full eligibility criteria are set by the study protocol. Our research team will review them with you, explain what participation involves, including visits, procedures and compensation where applicable, and answer your questions before you decide. Participation is voluntary, and you can withdraw at any time.
EndoTrials is the clinical research center of Diabetes & Endocrine Specialists, led by Darius A. Schneider, MD, PhD.